CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, M.
Right arrow Articles by Lee, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, M.
Right arrow Articles by Lee, A. H.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 713-718, August 2002
© 2002 American Association for Cancer Research

Tea Consumption and Ovarian Cancer Risk

A Case-Control Study in China1

Min Zhang, Colin W. Binns and Andy H. Lee2

School of Public Health, Curtin University of Technology, Perth, WA 6845 Australia

To investigate whether tea consumption has an etiological associationwith ovarian cancer, a case-control study was conducted in China during 1999–2000. The cases were 254 patients with histologically confirmed epithelial ovarian cancer. The 652 controls comprised 340 hospital visitors, 261 non-neoplasm hospital outpatients, and 51 women recruited from the community. Information on the frequency, type, and duration of tea consumption was collected by personal interview using a validated questionnaire. The risk of ovarian cancer for tea consumption was assessed using adjusted odds ratios based on multivariate logistic regression analysis, accounting for confounding demographic, lifestyle, and familial factors including hormonal status and family ovarian cancer. The ovarian cancer risk declined with increasing frequency and duration of overall tea consumption. The adjusted odds ratio was 0.39 for those drinking tea daily and 0.23 for those drinking tea for >30 years, compared with nontea drinkers. The dose response relationships were significant, and the inverse association with ovarian cancer was observed for green tea consumption. We concluded that increasing frequency and duration of tea drinking, especially green tea, can reduce the risk of ovarian cancer. However, the protective effects of black tea and Oolong tea need to be additionally investigated.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. J. Song, A. R. Kristal, K. G. Wicklund, K. L. Cushing-Haugen, and M. A. Rossing
Coffee, Tea, Colas, and Risk of Epithelial Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 712 - 716.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. O. Clarke and G. E. Mullin
A Review of Complementary and Alternative Approaches to Immunomodulation
Nutr Clin Pract, February 1, 2008; 23(1): 49 - 62.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Zhang, C. D. J. Holman, J.-p. Huang, and X. Xie
Green tea and the prevention of breast cancer: a case-control study in Southeast China
Carcinogenesis, May 1, 2007; 28(5): 1074 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. T. Chang, V. S. Lee, A. J. Canchola, C. A. Clarke, D. M. Purdie, P. Reynolds, H. Anton-Culver, L. Bernstein, D. Deapen, D. Peel, et al.
Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort
Am. J. Epidemiol., April 1, 2007; 165(7): 802 - 813.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
C. Cabrera, R. Artacho, and R. Gimenez
Beneficial effects of green tea--a review.
J. Am. Coll. Nutr., April 1, 2006; 25(2): 79 - 99.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. C. Larsson and A. Wolk
Tea Consumption and Ovarian Cancer Risk in a Population-Based Cohort
Arch Intern Med, December 12, 2005; 165(22): 2683 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
D. Seely, E. J. Mills, P. Wu, S. Verma, and G. H. Guyatt
The Effects of Green Tea Consumption on Incidence of Breast Cancer and Recurrence of Breast Cancer: A Systematic Review and Meta-analysis
Integr Cancer Ther, June 1, 2005; 4(2): 144 - 155.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Zhang, X. Xie, A. H. Lee, C. W. Binns, and C. D. J. Holman
Body Mass Index in Relation to Ovarian Cancer Survival
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1307 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. Borek
Dietary Antioxidants and Human Cancer
Integr Cancer Ther, December 1, 2004; 3(4): 333 - 341.
[Abstract] [PDF]


Home page
J. Nutr.Home page
V. Crespy and G. Williamson
A Review of the Health Effects of Green Tea Catechins in In Vivo Animal Models
J. Nutr., December 1, 2004; 134(12): 3431S - 3440S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Naasani, F. Oh-hashi, T. Oh-hara, W. Y. Feng, J. Johnston, K. Chan, and T. Tsuruo
Blocking Telomerase by Dietary Polyphenols Is a Major Mechanism for Limiting the Growth of Human Cancer Cells in Vitro and in Vivo
Cancer Res., February 15, 2003; 63(4): 824 - 830.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.